Metraipolis › archive › dc_71ba1d4e2e81

Novel application for the JAK inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study — Europe PMC PMID:41924279

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41924279
DOI
10.3389/fimmu.2026.1736522
License (as archived)
solo-consultazione
Archived
2026-11-04T08:21:38.802Z
SHA-256 of the archived text
e7a246309ea41de8d174e68a336bf92cd26eb1590f0e46f544277b8d9aa3b9d5
Stable URL of this page
https://metraipolis.com/documento/dc_71ba1d4e2e81

How to cite

Novel application for the JAK inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study — Europe PMC PMID:41924279 — Europe PMC (en), https://europepmc.org/article/MED/41924279 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71ba1d4e2e81 (Metraipolis archive dc_71ba1d4e2e81, sha256 e7a246309ea41de8d174e68a336bf92cd26eb1590f0e46f544277b8d9aa3b9d5)
BibTeX
@misc{dc71ba1d4e2e81,
  title = {Novel application for the JAK inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study — Europe PMC PMID:41924279},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41924279},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71ba1d4e2e81; sha256 e7a246309ea41de8d174e68a336bf92cd26eb1590f0e46f544277b8d9aa3b9d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41924279. Agents can read the archived copy with the MCP tool read_document.